Socioeconomic status, ABO phenotypes and risk of ischaemic heart disease: An 8-year follow-up in the copenhagen male study

European Journal of Preventive Cardiology

Volumn 7, Issue 4, 2000, Pages 277-283

  Suadicani, Poul ^a   Hein, Hans Ole ^a   Gyntelberg, Finn ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

ABO phenotypes; epidemiology; ischaemic heart disease; socioeconomic status

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; CARDIOVASCULAR RISK; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SOCIAL CLASS;

ABO BLOOD-GROUP SYSTEM; AGED; CHI-SQUARE DISTRIBUTION; CONFOUNDING FACTORS (EPIDEMIOLOGY); DENMARK; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OCCUPATIONS; PHENOTYPE; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SOCIAL CLASS;

EID: 84992801796     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/204748730000700406     Document Type: Article

References (30)

1. Suadicani P, Hein HO, Gyntelberg F. Strong mediators of social inequalities in risk of ischaemic heart disease. A six year follow-up in the Copenhagen Male Study. Int J Epidemiol 1997; 26: 516–522.
2. Beardmore JA, Karimi-Booshehri F. ABO genes are differentially distributed in socio-economic groups in England. Nature 1983; 303: 522–524.
3. Havlik RJ, Feinleib M, Garrison RJ, Kannel WB. Blood groups and coronary heart disease. Lancet 1969; 11: 269–270.
4. Whincup PH, Cook DG, Phillips AN, Shaper AG. ABO blood group and ischaemic heart disease in British men. BMJ 1990; 300: 1679–1682.
5. Mitchell JRA. An association between ABO blood-group distribution and geographical differences in death-rates. Lancet 1977; 1: 295–297.
6. Allan TM. ABO blood groups, age and work in ischaemic heart disease. Atherosclerosis 1975; 21: 459–461.
7. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 1994; 88: 601–607.
8. Erikssen J, Thaulow E, Stormorken H, Brendemoen O, Hellem A. ABO blood groups and coronary heart disease (CHD). A study in subjects with severe and latent CHD. Thromb Haemost 1980; 43: 137–140.
9. Lauridsen L, Gyntelberg F. A clinical follow-up five years after. Screening for hypertension in Copenhagen males aged 40–59. Int J Epidemiol 1979; 8: 11–14.
10. Gyntelberg F. One- and two-years incidence of myocardial infarction in Copenhagen males aged 40–59. Dan Med Bull 1975; 22: 81–84.
11. Gyntelberg F. Physical fitness and coronary heart disease in male residents in Copenhagen aged 40–59. Dan Med Bull 1973; 20: 1–4.
12. Hansen EJ. Socialgrupper i Danmark. Copenhagen: The Institute of Danish Social Science; 1984.
13. Svalastoga K. Prestige, class and mobility. Copenhagen: Munksgaard; 1959.
14. Suadicani P, Hein HO, Gyntelberg F. Serum cotinine validated form of smoking does not account for social inequalities in risk of ischaemic heart disease: the Copenhagen Male Study — 4 years' follow-up. Int J Epidemiol 1994; 23: 293–300.
15. Suadicani P, Hein HO, Gyntelberg F. Do physical and chemical working conditions explain the association of social class with ischaemic heart disease? Atherosclerosis 1995; 113: 63–69.
16. Rose GA, Holland WW, Crowley EA. A sphygmomanometer for epidemiologists. Lancet 1964; 1: 296–300.
17. Suadicani P, Hein HO, Gyntelberg F. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 1992; 96: 33–42.
18. Alfthan G, Kumpulainen J. Determination of selenium in small volumes of plasma and serum by electrothermal atomic absorption spectrometry. Anal Chim Acta 1982; 140: 221–227.
19. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride concentration and ischaemic heart disease. An eight-year follow-up in the Copenhagen Male Study. Circulation 1998; 97: 1029–1036.
20. Fridewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
21. Norusis M. SPSS for Windows: base system users guide, release 6.0. Chicago, IL: SPSS; 1994.
22. Norusis M. SPSS for Windows: advanced statistics, release 6.1. Chicago, IL: SPSS; 1994.
23. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley-Interscience; 1989.
24. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiological research. Principles and quantitative methods. London: Lifetime Learning Publications; 1982.
25. Mourant AE, Kopec AC, Damaniewska-Sobczak K. The distribution of the human blood groups and other polymorphisms. London: Oxford University Press; 1976.
26. Fischer A, Gutstein DE, Fuster V. Thrombosis and coagulation abnormalities in the acute coronary syndromes. Cardiol Clin 1999; 17: 283–294.
27. Ordonez A.J. Gonzalez, Rodriguez JM Medina, Martin L, Alvarez V, Coto E. The O blood group protects against venous thromboembolism in individuals with the factor V Leiden but not the prothrombin (factor II G20210A) mutation. Blood Coagul Fibrinolysis 1999; 10: 303–307.
28. Philips MD, Santhouse A. Von Willebrand disease: recent advances in pathophysiology and treatment. Am J Med Sci 1998; 316: 77–86.
29. Jeremie M, Weisert O, Gedde-Dahl TW. Factor VIII (AHG) levels in 1016 regular blood donors. The effects of age, sex, and ABO blood groups. Scand J Clin Lab Invest 1976; 36: 461–466.
30. Gillum RF. Blood groups, serum cholesterol, serum uric acid, blood pressure, and obesity in adolescents. J Natl Med Assoc 1991; 83: 682–688.